Search results
11 mar 2023 · Radical treatments (prostatectomy or radiotherapy) reduced the incidence of metastasis, local progression, and long-term androgen-deprivation therapy by half as compared with active monitoring.
- Perspective Access to Biomedical Innovation — Inside The Legal Labyrinth A.K. Rai
Pierre-Henri Duée, Sophie Crozier, Florence Jusot,...
- Interactive Medical Case Thinking Outside The Heart R.A. Denu and Others
A 50-year-old woman presented to the ED with pleuritic chest...
- Perspective Toxidrome Recognition and Response G.R. Ciottone, D. Longo, and D. Taichman
Fifteen-Year Outcomes after Monitoring, Surgery, or...
- Editorial Genomics in Clinical Practice J.E. Posey and J.R. Lupski
In a remarkable study notable for its scale (>13,500...
- Then and Now O. Sartor
Between 1999 and 2009 in the United Kingdom, 82,429 men...
- Editorial Audio Interview
In this audio interview conducted on April 24, 2023, the...
- Original Article Randomized Trial of BCG Vaccine to Protect Against Covid-19 in Health Care Workers L.F. Pittet and Others
The bacille Calmette–Guérin (BCG) vaccine has...
- Clinical Decisions Dietary Sodium Restriction in Patients With Heart Failure L.L. Chang and Others
This feature about a patient with heart failure offers a...
- Perspective Access to Biomedical Innovation — Inside The Legal Labyrinth A.K. Rai
13 paź 2016 · The comparative effectiveness of treatments for prostate cancer that is detected by prostate-specific antigen (PSA) testing remains uncertain. We compared active monitoring, radical...
19 kwi 2022 · External beam radiation for prostate cancer includes intensity-modulated, image-guided radiation therapy (IG-IMRT), typically delivered over five weeks, and hypofractionated radiation therapy (what we call MSK Precise ™), typically delivered over a week and a half in five total treatments.
1 lut 2019 · Bayesian Multistate Model Fit to Prostate Cancer Data With Interactions. Hazard ratio (HR) estimates from the multistate model for each covariate by treatment. For each covariate, the point estimate and 95% CI are shown. CF indicates clinical failure; PSA, prostate-specific antigen.
8 lut 2019 · Mantz C. A phase II trial of stereotactic ablative body radiotherapy for low-risk prostate cancer using a non-robotic linear accelerator and real-time target tracking: report of toxicity, quality of life, and disease control outcomes with 5-year minimum follow-up.
10 sie 2022 · Our long-term results show that MRI-guided boost to prostate cancer lesions is feasible and associated with low long-term morbidity. Recently, there has been a shift in the radiation treatment paradigm for prostate cancer toward hypofractionation (Table 3).
22 lut 2024 · Combined androgen deprivation therapy (ADT) and radiotherapy (RT) improves outcomes for intermediate and high-risk prostate cancer. Treatment intensification with abiraterone acetate/prednisone...
